Day-care Unit for Patients With Refractory Heart Failure

Last updated: May 25, 2020
Sponsor: Silesian Centre for Heart Diseases
Overall Status: Active - Enrolling

Phase

N/A

Condition

Heart Failure

Chest Pain

Congestive Heart Failure

Treatment

N/A

Clinical Study ID

NCT03056651
DayCare-HF
DCHFU
  • Ages > 18
  • All Genders

Study Summary

The Day-Care Unit for Patients With Refractory Heart Failure (DayCare-HF) is an observational study on selected patients with advanced refractory heart failure. The purpose of the study was to examine the comprehensive management of HF in the day-care unit in terms of the safety and its impact on the rehospitalization and mortality rates in patients with advanced refractory HF.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Optimally decongested heart failure in New York Heart Association (NYHA) class II-IV,treated for at least 6 months

  2. Performance of all possible reparative procedures if indications were present (cardiacrevascularization, correction of valvular heart disease, cardiac ablation, cardiacresynchronization therapy)

  3. Implantation of cardioverter-defibrillator (ICD) if applicable

  4. At least two unplanned hospitalizations for heart failure during preceding 6 months

Exclusion

Exclusion Criteria:

  1. Inability to travel to the unit

  2. Non-compliance with the medical recommendations

Study Design

Total Participants: 200
Study Start date:
April 01, 2016
Estimated Completion Date:
December 31, 2022

Study Description

The Day-Care Unit for Patients With Refractory Heart Failure (DayCare-HF) is a single-center observational study conducted in the 3rd Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Disease in Zabrze, Poland.

The main objective of the DayCare-HF is to verify the hypothesis that comprehensive and multidisciplinary day-care management of patients with refractory heart failure (HF) is safe and beneficial in terms of hospital readmission due to HF and al cause mortality.

The study population is formed by selected patients with heart failure, hospitalized in cardiology wards and intensive cardiac care unit of Silesian Centre for Heart Disease, who fulfilled eligibility criteria.

During the scheduled visits comprehensive medical service is provided, including education, diagnostic tools (electrocardiography, transthoracic echocardiography, implanted cardioverter defibrillator (ICD) / cardiac resynchronization therapy device (CRT) interrogation and additional treatment (intravenous loop diuretic, dobutamine, vasodilators administration).

The patients are under constant follow-up for major adverse events, heart transplantation, hospital readmissions due to HF and all cause mortality.

Connect with a study center

  • Silesian Centre for Heart Disease

    Zabrze, Silesia 41-800
    Poland

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.